Inactive Instrument

News Quint Media Inc Other OTC

Equities

US74874T1043

End-of-day quote Other OTC Other stock markets
- ^USD	-

Feb. 20	Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
Jan. 05	Theralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Theralink Technologies : Accelaration/Increase of Financial Obligation - Form 8-K	Mar. 06	PU
Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 20	CI
Theralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Jan. 05	CI
Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates	Dec. 18	AQ
Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4	Nov. 13	AQ
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board	Nov. 03	AQ
Theralink Technologies, Inc. Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute?s Molecular Tumor Board	Nov. 03	CI
Four Penny Stocks That Might Move On News (EPAZ, THER, SDNR, HNRC)	23-10-05	AQ
Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023	23-10-04	AQ
Theralink Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-21	CI
IMAC Holdings, Inc. announced that it has received $4.3 million in funding from Theralink Technologies, Inc. and other investors	23-07-25	CI
Theralink Technologies, Inc. Announces Chief Executive Officer Changes	23-06-27	CI
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer	23-06-27	AQ
Theralink Technologies, Inc. Appoints Mick Ruxin as Chief Medical Officer	23-06-27	CI
Theralink Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-15	CI
Theralink Technologies, Inc. entered into a definitive agreement and plan of merger to acquire IMAC Holdings, Inc. for $0.9 million in a reverse merger transaction.	23-05-14	CI
Theralink Technologies, Inc. Announces Termination of Thomas Chilcott as Treasurer and Secretary	23-05-11	CI
Theralink Technologies, Inc. Announces CFO Changes	23-05-11	CI
Theralink Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University	23-04-04	AQ
Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University	23-04-03	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Quint Media Inc Other OTC

Equities

US74874T1043

Summary

Filters